These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

194 related items for PubMed ID: 2966402

  • 1. EORTC protocol 30805: a phase III trial comparing orchidectomy versus orchidectomy and cyproterone acetate and low dose stilboestrol in the management of metastatic carcinoma of the prostate.
    Robinson MR.
    Prog Clin Biol Res; 1988; 260():101-10. PubMed ID: 2966402
    [No Abstract] [Full Text] [Related]

  • 2. Complete androgen blockade: the EORTC experience comparing orchidectomy versus orchidectomy plus cyproterone acetate versus low-dose stilboestrol in the treatment of metastatic carcinoma of the prostate.
    Robinson MR.
    Prog Clin Biol Res; 1987; 243A():383-90. PubMed ID: 2958863
    [No Abstract] [Full Text] [Related]

  • 3. The final analysis of the EORTC Genito-Urinary Tract Cancer Co-Operative Group phase III clinical trial (protocol 30805) comparing orchidectomy, orchidectomy plus cyproterone acetate and low dose stilboestrol in the management of metastatic carcinoma of the prostate.
    Robinson MR, Smith PH, Richards B, Newling DW, de Pauw M, Sylvester R.
    Eur Urol; 1995; 28(4):273-83. PubMed ID: 8575493
    [Abstract] [Full Text] [Related]

  • 4. EORTC protocol 30761: a randomized study of non-metastatic and metastatic prostatic cancer treated by cyproterone acetate versus diethylstilbestrol and medroxyprogesterone acetate. European Organization for Research on Treatment of Cancer Urological Group.
    Pavone-Macaluso M, Schröder FH, de Voogt HJ, Viggiano G, Barasolo E, Lardennois B, de Pauw M, Sylvester R, Smith PH, Suciu S.
    Prog Clin Biol Res; 1989; 303():111-6. PubMed ID: 2528735
    [No Abstract] [Full Text] [Related]

  • 5. Cyproterone acetate versus medroxyprogesterone acetate versus diethylstilbestrol in the treatment of prostate cancer: results from EORTC Study 30761.
    Pavone-Macaluso M, Ingargiola GB, de Voogt H, Viggiano G, Barasolo E, Lardennois B, De Pauw M, Sylvester R.
    Prog Clin Biol Res; 1987; 243A():379-82. PubMed ID: 2958862
    [No Abstract] [Full Text] [Related]

  • 6. Lessons from phase III-trials on the hormonal treatment of prostatic cancer. I: Results of EORTC-trials 30761 and 30762.
    de Voogt HJ, Pavone-Macaluso M, Smith PH, de Pauw M, Suciu S.
    Prog Clin Biol Res; 1988; 260():111-7. PubMed ID: 2966403
    [No Abstract] [Full Text] [Related]

  • 7. Results of a Dutch trial with the LHRH agonist buserelin in patients with metastatic prostatic cancer and results of EORTC studies in prostatic cancer.
    Debruyne FM.
    Am J Clin Oncol; 1988; 11 Suppl 1():S33-5. PubMed ID: 2968760
    [Abstract] [Full Text] [Related]

  • 8. Management of metastatic prostatic carcinoma.
    Drug Ther Bull; 1986 Nov 03; 24(22):85-8. PubMed ID: 2430768
    [No Abstract] [Full Text] [Related]

  • 9. [Treatment of prostatic cancer: medroxyprogesterone acetate, diethylstilbestrol and cyproterone acetate. Provisional report of a random study by the genito-urinary cooperative group of the EORTC].
    Pavone-Macaluso M, Martínez-Piñeiro JA, de Voogt H, Lardennois B, Nasta A, Zolfanelli R, Barasolo E, De Pauw M, Suciu S, Sulvester R.
    Arch Esp Urol; 1982 Nov 03; 35(5):304-11. PubMed ID: 6217788
    [No Abstract] [Full Text] [Related]

  • 10. Is there a best endocrine management of prostatic carcinoma?
    Robinson MR.
    Prog Clin Biol Res; 1988 Nov 03; 269():147-58. PubMed ID: 2969114
    [No Abstract] [Full Text] [Related]

  • 11. EORTC protocols in prostatic cancer. An interim report.
    Pavone-Macaluso M, Lund F, Mulder JH, Smith PH, De Pauw M, Sylvester R.
    Scand J Urol Nephrol Suppl; 1980 Nov 03; 55():163-8. PubMed ID: 6938020
    [Abstract] [Full Text] [Related]

  • 12. Comparison of diethylstilbestrol, cyproterone acetate and medroxyprogesterone acetate in the treatment of advanced prostatic cancer: final analysis of a randomized phase III trial of the European Organization for Research on Treatment of Cancer Urological Group.
    Pavone-Macaluso M, de Voogt HJ, Viggiano G, Barasolo E, Lardennois B, de Pauw M, Sylvester R.
    J Urol; 1986 Sep 03; 136(3):624-31. PubMed ID: 2942707
    [Abstract] [Full Text] [Related]

  • 13. [Treatment of cancer of the prostate. New hormonal approaches].
    Schaison G.
    Pathol Biol (Paris); 1989 Feb 03; 37(2):118-9. PubMed ID: 2523530
    [No Abstract] [Full Text] [Related]

  • 14. A further analysis of European Organization for Research and Treatment of Cancer protocol 30805. Orchidectomy versus orchidectomy plus cyproterone acetate versus low-dose diethylstilbestrol.
    Robinson MR.
    Cancer; 1993 Dec 15; 72(12 Suppl):3855-7. PubMed ID: 8252503
    [No Abstract] [Full Text] [Related]

  • 15. Hormonal therapy trials in prostatic cancer. An EORTC Genitourinary Group study.
    Bollack C, Rougeron G.
    Am J Clin Oncol; 1988 Dec 15; 11 Suppl 2():S156-9. PubMed ID: 2977270
    [Abstract] [Full Text] [Related]

  • 16. Orchiectomy combined with cyproterone acetate or prednisone in the treatment of advanced prostatic carcinoma. A randomized clinical and endocrine study.
    Sander S, Nissen-Meyer R, Aakvaag A.
    Scand J Urol Nephrol; 1982 Dec 15; 16(3):193-7. PubMed ID: 6219455
    [Abstract] [Full Text] [Related]

  • 17. [Cyproterone acetate in the treatment of post-orchiectomy flushing].
    Jansen JE, Hendriksen ON.
    Ugeskr Laeger; 1989 Feb 27; 151(9):560-1. PubMed ID: 2522257
    [Abstract] [Full Text] [Related]

  • 18. Orchidectomy versus Buserelin in combination with cyproterone acetate, for 2 weeks or continuously, in the treatment of metastatic prostatic cancer. Preliminary results of EORTC-trial 30843.
    de Voogt HJ, Klijn JG, Studer U, Schröder F, Sylvester R, De Pauw M.
    J Steroid Biochem Mol Biol; 1990 Dec 20; 37(6):965-9. PubMed ID: 2149509
    [Abstract] [Full Text] [Related]

  • 19. [Cancers of the prostate and cyproterone acetate. Value of blood testosterone and PSA levels for treatment surveillance].
    Aubert J, Dore B, Irani J, Bon D.
    J Urol (Paris); 1990 Dec 20; 96(8):431-5. PubMed ID: 1707083
    [Abstract] [Full Text] [Related]

  • 20. Treatment of advanced prostatic carcinoma with cyproterone acetate and orchiectomy--5-year follow-up.
    Giuliani L, Pescatore D, Giberti C, Martorana G, Natta G.
    Eur Urol; 1980 Dec 20; 6(3):145-8. PubMed ID: 7371659
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.